DENTSPLY SIRONA Inc (NASDAQ:XRAY) Expected to Announce Earnings of $0.74 Per Share

Analysts expect that DENTSPLY SIRONA Inc (NASDAQ:XRAY) will post earnings per share of $0.74 for the current fiscal quarter, Zacks reports. Seven analysts have provided estimates for DENTSPLY SIRONA’s earnings, with the highest EPS estimate coming in at $0.76 and the lowest estimate coming in at $0.72. DENTSPLY SIRONA reported earnings of $0.58 per share during the same quarter last year, which indicates a positive year-over-year growth rate of 27.6%. The firm is scheduled to issue its next earnings results on Friday, March 6th.

According to Zacks, analysts expect that DENTSPLY SIRONA will report full year earnings of $2.45 per share for the current year, with EPS estimates ranging from $2.43 to $2.48. For the next fiscal year, analysts forecast that the firm will report earnings of $2.70 per share, with EPS estimates ranging from $2.62 to $2.82. Zacks’ earnings per share calculations are a mean average based on a survey of sell-side research analysts that that provide coverage for DENTSPLY SIRONA.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.57 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.50 by $0.07. The business had revenue of $962.10 million during the quarter, compared to analysts’ expectations of $940.38 million. DENTSPLY SIRONA had a return on equity of 10.08% and a net margin of 4.08%. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same period in the previous year, the business posted $0.38 earnings per share.

Several brokerages have weighed in on XRAY. Barrington Research reissued a “buy” rating and set a $63.00 price objective on shares of DENTSPLY SIRONA in a report on Monday, August 5th. ValuEngine cut shares of DENTSPLY SIRONA from a “hold” rating to a “sell” rating in a research report on Wednesday, October 2nd. BidaskClub raised DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Saturday, November 9th. Finally, HC Wainwright restated a “hold” rating and issued a $60.00 price target on shares of DENTSPLY SIRONA in a research report on Friday, November 15th. One analyst has rated the stock with a sell rating, eight have given a hold rating and three have assigned a buy rating to the company’s stock. DENTSPLY SIRONA has a consensus rating of “Hold” and a consensus price target of $56.08.

Shares of XRAY traded up $0.46 during trading hours on Tuesday, hitting $57.16. 22,036 shares of the stock traded hands, compared to its average volume of 1,605,077. The business has a fifty day moving average of $55.68 and a 200-day moving average of $54.68. The firm has a market capitalization of $12.58 billion, a PE ratio of 28.41, a price-to-earnings-growth ratio of 1.98 and a beta of 0.95. DENTSPLY SIRONA has a 1-year low of $34.93 and a 1-year high of $60.15. The company has a current ratio of 2.08, a quick ratio of 1.39 and a debt-to-equity ratio of 0.30.

In other DENTSPLY SIRONA news, Director Michael C. Alfano sold 10,665 shares of the stock in a transaction on Tuesday, November 12th. The shares were sold at an average price of $56.27, for a total value of $600,119.55. Following the sale, the director now directly owns 15,153 shares in the company, valued at $852,659.31. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. 0.62% of the stock is currently owned by corporate insiders.

Hedge funds have recently made changes to their positions in the company. Altshuler Shaham Ltd lifted its stake in DENTSPLY SIRONA by 209.8% in the second quarter. Altshuler Shaham Ltd now owns 505 shares of the medical instruments supplier’s stock valued at $30,000 after buying an additional 342 shares in the last quarter. Quest Capital Management Inc. ADV acquired a new stake in shares of DENTSPLY SIRONA in the 3rd quarter valued at about $30,000. Rational Advisors LLC lifted its holdings in shares of DENTSPLY SIRONA by 102.7% in the third quarter. Rational Advisors LLC now owns 675 shares of the medical instruments supplier’s stock valued at $36,000 after purchasing an additional 342 shares in the last quarter. Van ECK Associates Corp bought a new stake in shares of DENTSPLY SIRONA in the second quarter valued at about $54,000. Finally, Coastal Investment Advisors Inc. boosted its position in shares of DENTSPLY SIRONA by 309.7% during the third quarter. Coastal Investment Advisors Inc. now owns 1,184 shares of the medical instruments supplier’s stock worth $63,000 after buying an additional 895 shares during the period. 94.35% of the stock is owned by institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

Further Reading: How to track put option volume

Get a free copy of the Zacks research report on DENTSPLY SIRONA (XRAY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.